November 10, 2020 01:15 pm ETEstimated Read Time: 4 Minutes
France has been accused of falling behind in the cannabis race and has thus been urged to take action on medical cannabis before they’re left behind. In response, the French government announced that they will be carrying out a medical cannabis experiment which will involve distributing free medical cannabis.
About the Experiment
The experiment consists of a two-year cycle where up to 3,000 patients will be treated with medical cannabis. The experiment will allow participating companies to import cannabis and the companies who wish to participate in the experiment will be obliged to give participants free medical cannabis which has to comply with the pharmaceutical standards and good manufacturing practice.
The experiment will only last two years long and is set to start with the first prescription in March 2021. Despite the fact that there are still months before the start of this experiment, Nicolas Authier (chair of the French Agency for Safety of Medicines and Health Products, or ANSM) stated that France is now officially committed to giving citizens access to medical cannabis.
The experiment will take place under the decree of the Ministry of Health and Solidarity, who will also be responsible for the execution of the experiment. In conjunction with the ANSM, the Ministry of Health and Solidarity will decide on the following:
The characteristics, composition, pharmaceutical form, and technical specifications of the medical cannabis products.
The list of qualifying conditions in which physicians will use a guide for those who may be prescribed medical cannabis in the experiment.
The procedures for importing, storing, distributing, and controlling medical cannabis.
In an interview with Marijuana Business Daily, Nicolas Authier explained that since cannabis with higher quantities of THC is illegal, most of the cannabis supplies will probably come from foreigners for the sake of the experiment. The ANSM plans to implement a patient registry which will be updated by doctors and pharmacies after getting consent from patients. They plan on using the registry in order to monitor the effects of medical cannabis. By doing this, they have the opportunity to assess previously unreported adverse effects, if any at all.
Apply For Your Medical Marijuana Card Today
Veriheal has satisfied hundreds of thousands of patients nationwide
Get approved or your money back
Appointments available on-demand
Customer support available 24/7
The experiment aims to allow only trained doctors to prescribe cannabis and that prescriptions be fulfilled at a hospital pharmacy. The experiment will not allow cannabis to be prescribed for smoking and will only allow for cannabis intended for ingestion or vaporizing. The qualifying conditions in this experiment include (1) chronic pain that is untreated by current therapies, (2) severe and refractory epilepsy, (3) supportive oncology care, (4) palliative care, and (5) multiple sclerosis spasticity.
In preparation for the implementation of prescribing cannabis, ANSM will put its energy into securing cannabis supply, organizing the training of doctors and pharmacists who will be prescribing and dispensing the cannabis as well as generating the register for monitoring patients
The experiment is planned, but the budget required to carry it out is still pending approval from the French parliament.
Cultivating, selling, and possessing cannabis intended for recreational use still remains illegal in France, despite being a popular recreational anecdote. In 2013, France legalized medication containing cannabis such as the well-known Sativex. This means that patients with prescriptions from a licensed physician may consume and possess cannabis. In 2017/18, president Emmanuel Macron saw to the reduction of the penalties for possessing cannabis (without a valid prescription), which was reduced from a criminal charge to a fine or warning.
It’s speculated that if this experimental program becomes permanent, France has the potential of becoming one of the biggest cannabis markets in the European Union. Going from being accused of falling behind to taking the reins, France has found itself amongst the first countries to implement such a large-scale experiment on medical cannabis in actual humans. Here’s to hoping that their experiment yields pleasing enough results to ignite interest in the medical properties of cannabis in other countries.
Blunts: What are they exactly, and how do they affect your body? If you’re interested in smoking blunts—or already smoke them—this guide is for you. We’ll cover everything you need to know about this popular cannabis intake method, including how they’re made, how they differ from spliffs and joints, risks of use, and alternative intake…
“Stoned,” “high,” “tripping,” and “baked,” are all terms engrained in the cannabis community. These metaphorical descriptions contribute to how we perceive, interpret, and learn from the experiences produced by cannabis consumption. Cannabis experiences, of course, are unique and highly variable. Specific plant strains, the presence of other cannabinoids, different delivery methods, and a user’s individual…
Thanks to the growing wave of legalization, more consumers than ever can grow their own cannabis right at home. Growing essentials that used to be secretive are now bought and sold freely. This includes items, like grow tents, nutrients, LED lighting, HPS lighting, ventilation, and more. Keeping all these items straight is hard enough, but…
Skin diseases plague millions of individuals, inflicting both physical discomforts in addition to mental and social stress. Thankfully, there is no shortage of skin treatment options available on the market. That said, this established market may soon be in for a major shake-up if recent cannabis research is any indication. Traditionally, cannabis research focused on studying…
As more states move toward legalization, accurately detecting impaired driving is of the utmost importance. Field Sobriety Tests (FSTs) have long been the go-to method for law enforcement to assess driver impairment caused by substances like alcohol. However, a recent 2023 study published in JAMA Psychiatry raises serious questions about the accuracy of these tests…
The statements made regarding cannabis products on this website have not been evaluated by the Food and Drug Administration (FDA). Cannabis is not an FDA-approved substance and is still illegal under federal law. The information provided on this website is intended for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. It is not intended as medical advice and should not be considered as a substitute for advice from a healthcare professional. We strongly recommend that you consult with a physician or other qualified healthcare provider before using any cannabis products. The use of any information provided on this website is solely at your own risk.